Uchiyama, Kazuhiko
Sakiyama, Toshio
Hasebe, Takumu
Musch, Mark W.
Miyoshi, Hiroyuki
Nakagawa, Yasushi
He, Tong-Chuan
Lichtenstein, Lev
Naito, Yuji
Itoh, Yoshito
Yoshikawa, Toshikazu
Jabri, Bana
Stappenbeck, Thaddeus
Chang, Eugene B.
Article History
Received: 24 May 2016
Accepted: 1 August 2016
First Online: 26 August 2016
Competing interests
: Dr. Yoshito Itoh has an affiliation with a donation-funded department from AstraZeneca Co., Ltd., Eisai Co., Ltd., Otsuka Pharmaceutical Co., Ltd., MSD K.K., Dainippon Sumitomo Pharma Co., Ltd., Chugai Pharmaceutical Co., Ltd., FUJIFILM Medical Co., Ltd. and Merck Serono Co., Ltd. Yuji Naito received scholarship funds from Eisai Co., Ltd., Astellas Pharma Inc., Takeda Pharmaceutical Co., Ltd., and Mitsubishi Tanabe Pharma Co., Ltd. Yoshito Itoh received scholarship funds from MSD K.K. and Bristol-Myers K.K. The other authors have no conflicts of interest to declare.